×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [4]
Institute of Chi... [3]
INSTITUTE OF APP... [1]
THE STATE KEY LA... [1]
Authors
ZHAO QI [3]
CHUXIA DENG [1]
LUO QIAN [1]
LIU TZU MING [1]
XIAOHUA DOUGLAS ... [1]
WANG RUIBING [1]
More...
Document Type
Journal article [6]
Review article [1]
Date Issued
2024 [4]
2023 [1]
2020 [1]
2017 [1]
Language
英語English [7]
Source Publication
Journal of Manuf... [2]
Antibodies [1]
Journal of Contr... [1]
Journal of the E... [1]
ONCOTARGET [1]
Theranostics [1]
More...
Indexed By
SCIE [5]
ESCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-7 of 7
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells
Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:
Zhou, Guangyu
;
Fu, Shengyu
;
Zhang, Yunsen
;
Li, Shuang
;
Guo, Ziang
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.0
/
4.7
|
Submit date:2024/08/05
Car-t Cell
Her2
Monoclonal Antibody
Trastuzumab
Surface selective oxidation of C/C composites by ultrafast high-temperature shock for enhancing interfacial bonding with metal
Journal article
Yan, Yaotian, Zhang, Jingkang, Zhang, Tianlei, Zhang, Junjie, Li, Peixin, Wang, Bin, Lin, Jinghuang, Cao, Jian, Qi, Junlei. Surface selective oxidation of C/C composites by ultrafast high-temperature shock for enhancing interfacial bonding with metal[J]. Journal of the European Ceramic Society, 2024, 44(5), 3121-3130.
Authors:
Yan, Yaotian
;
Zhang, Jingkang
;
Zhang, Tianlei
;
Zhang, Junjie
;
Li, Peixin
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
5.8
/
5.7
|
Submit date:2024/02/22
C/c Composites
Interfacial Bonding
Low Thermal Damage
Surface Selective Oxidation
Ultrafast High-temperature Shock
Characteristics, applications and perspective of high entropy alloys for interfacial joining: A review
Review article
2024
Authors:
Li, Peixin
;
Zhang, Jingkang
;
Yang, Taili
;
Zhang, Tianlei
;
Zhang, Junjie
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
8
IF:
6.1
/
6.2
|
Submit date:2024/02/22
High Entropy Alloy
Interfacial Joining
Wettability Characteristics
Characteristics, applications and perspective of high entropy alloys for interfacial joining: A review
Journal article
Li, Peixin, Zhang, Jingkang, Yang, Taili, Zhang, Tianlei, Zhang, Junjie, Lin, Jinghuang, Yan, Yaotian, Li, Chun, Si, Xiaoqing, Cao, Jian, Qi, Junlei. Characteristics, applications and perspective of high entropy alloys for interfacial joining: A review[J]. Journal of Manufacturing Processes, 2024, 110, 303-317.
Authors:
Li, Peixin
;
Zhang, Jingkang
;
Yang, Taili
;
Zhang, Tianlei
;
Zhang, Junjie
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
8
IF:
6.1
/
6.2
|
Submit date:2024/05/16
High entropy alloy
Interfacial joining
Wettability characteristics
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment
Journal article
Huang Shigao, Xing Fuqiang, Dai Yeneng, Zhang Zhiming, Zhou Guangyu, Yang Shuo, Liu Yu-Cheng, Yuan Zhen, Luo Kathy Qian, Ying Tianlei, Chu Dafeng, Liu Tzu-Ming, Deng Chu-Xia, Zhao Qi. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment[J]. Journal of Controlled Release, 2023, 362, 524-535.
Authors:
Huang Shigao
;
Xing Fuqiang
;
Dai Yeneng
;
Zhang Zhiming
;
Zhou Guangyu
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
4
IF:
10.5
/
10.6
|
Submit date:2023/09/28
Car-nk Cells
Tumor Microenvironment
Three-dimensional Slice Culture
Photothermal Therapy
Intravital Two-photon Imaging
Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine
Journal article
Sun,Tianlei, Kwong,Cheryl H.T., Gao,Cheng, Wei,Jianwen, Yue,Ludan, Zhang,Jianxiang, Dequan Ye,Richard, Wang,Ruibing. Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine[J]. Theranostics, 2020, 10(22), 10106-10119.
Authors:
Sun,Tianlei
;
Kwong,Cheryl H.T.
;
Gao,Cheng
;
Wei,Jianwen
;
Yue,Ludan
; et al.
Favorite
|
TC[WOS]:
95
TC[Scopus]:
97
IF:
12.4
/
12.0
|
Submit date:2021/03/02
Biomimetic Materials
Cyclodextrin
Macrophage Polarization
Ros-responsive
Ulcerative Colitis
A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A
Journal article
Xu, Tianshu, Ying, Tianlei, Wang, Lili, Zhang, Xiaohua Douglas, Wang, Ying, Kang, Lishan, Huang, Tao, Cheng, Liang, Wang, Liping, Zhao, Qi. A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A[J]. ONCOTARGET, 2017, 8(47), 81860-81872.
Authors:
Xu, Tianshu
;
Ying, Tianlei
;
Wang, Lili
;
Zhang, Xiaohua Douglas
;
Wang, Ying
; et al.
Favorite
|
TC[WOS]:
22
TC[Scopus]:
21
IF:
5.168
/
5.312
|
Submit date:2018/10/30
Bispecific Antibody
Fc Heterodimerization
Tnf-alpha
Il-17
Rheumatoid Arthritis
Immunology And Microbiology Section
Immune Response
Immunity